NCT04567849

Brief Summary

In the present study, patients will be sent a message shortly after completing a medical procedure that informs or reminds them that they can reach out to Geisinger, and how to do it, if they have any medical issues or concerns. Researchers will assess if such messages make patients more likely to contact Geisinger with post-procedure medical concerns and decrease emergency department utilization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11,546

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 29, 2020

Completed
1.1 years until next milestone

Study Start

First participant enrolled

November 16, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
Last Updated

July 18, 2023

Status Verified

July 1, 2023

Enrollment Period

1.6 years

First QC Date

September 23, 2020

Last Update Submit

July 14, 2023

Conditions

Emergency TreatmentTelephone Hotlines

Keywords

Behavioral EconomicsPatient Portal

Outcome Measures

Primary Outcomes (2)

  • Phone calls

    Proportion of patients who call the tele-nurse or their provider within 30 days of their appointment

    18 months or as long as it takes to reach N=17,300, whichever occurs first

  • ED utilization

    Proportion of patients who visit the ED within 30 days of their appointment

    18 months or as long as it takes to reach N=17,300, whichever occurs first

Secondary Outcomes (6)

  • Phone calls

    12 months

  • ED utilization

    12 months

  • Phone calls - surgical patients only

    18 months or as long as it takes to reach N=17,300, whichever occurs first

  • ED utilization - surgical patients only

    18 months or as long as it takes to reach N=17,300, whichever occurs first

  • Phone calls - surgical patients only

    12 months

  • +1 more secondary outcomes

Study Arms (3)

Control

NO INTERVENTION

No intervention control group

Nudge: call provider

EXPERIMENTAL

This group will receive a patient portal message the morning after completing their procedure. The message will encourage patients to call their recent Women's Health provider (with appropriate phone number listed) if any questions or concerns arise about their healthcare.

Behavioral: messageBehavioral: provider

Nudge: call tele-nurse

EXPERIMENTAL

This group will receive a patient portal message the morning after completing their procedure. The message will encourage patients to call Geisinger's nurse triage hotline (with appropriate phone number listed) if any questions or concerns arise about their healthcare.

Behavioral: messageBehavioral: tele-nurse

Interventions

messageBEHAVIORAL

patient portal message

Nudge: call providerNudge: call tele-nurse
providerBEHAVIORAL

nudging calling the patient's provider

Nudge: call provider
tele-nurseBEHAVIORAL

nudging calling the tele-nurse

Nudge: call tele-nurse

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patient had a procedure in Women's Health within the study period (including both surgical and in-office procedures as well as baby delivery)
  • Patient is enrolled in myGeisinger, Geisinger's patient portal

You may not qualify if:

  • If procedure was labor that resulted in fetal demise or stillborn.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geisinger

Danville, Pennsylvania, 17822, United States

Location

Study Officials

  • Amir Goren, PhD

    Geisinger Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participants (i.e., patients) will not be informed specifically of their assignment to different arms throughout the study. Providers will not be randomized to study arms or informed of patient assignment.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Throughout the study, patients will be randomized equally across all three arms.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Program Director, Behavioral Insights Team

Study Record Dates

First Submitted

September 23, 2020

First Posted

September 29, 2020

Study Start

November 16, 2021

Primary Completion

June 15, 2023

Study Completion

June 15, 2023

Last Updated

July 18, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency.

Shared Documents
ANALYTIC CODE
Time Frame
The data will become available after publication of study results in a scientific journal and will be available as long as the Open Science Framework hosts the data.
Access Criteria
The data on the Open Science Framework will be open to anyone requesting that information.
More information

Locations

US(1)